Nuclear Radiology: Page 16

Can mobile phones affect gamma camera performance?
By Wayne Forrest
Mobile phones can sometimes be a nuisance in daily life, but in a nuclear medicine suite, electromagnetic interference emitted by phones could even adversely affect the performance of gamma cameras, according to a study published in the March issue of the Journal of Medical Imaging and Radiation Sciences.
February 26, 2019
2019 02 22 17 28 8677 Phone Iphone 400
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
February 24, 2019
FFNP-PET could aid breast cancer treatment evaluation
By AuntMinnie.com staff writers
PET imaging with fluoro furanyl norprogesterone (FFNP) could provide a new option for measuring changes in progesterone receptor levels due to estrogen treatment for breast cancer, according to a study published in the February issue of the Journal of Nuclear Medicine.
February 11, 2019
2019 02 12 21 39 5333 F 18 Ffnp Pet Mice Images 245
SPECT, MRI together advance arrhythmia treatment
By AuntMinnie.com staff writers
The combination of information from cardiac MRI and iodine-123 metaiodobenzylguanidine (I-123 MIBG) SPECT shows promise for improving current ablation strategies for ventricular tachycardia, according to research published in the January issue of the Journal of Nuclear Medicine.
February 4, 2019
2017 02 10 15 45 57 410 Heart 400
SNMMI, ACNM oppose relaxing radiopharma user rules
By Wayne Forrest
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American College of Nuclear Medicine (ACNM) have submitted a joint statement opposing any changes in the U.S. Nuclear Regulatory Commission's training and experience requirements for healthcare personnel to administer radiopharmaceuticals.
January 30, 2019
2019 01 05 00 38 5275 Molecular Imaging 400
ANMI inks deal for SPECT radiopharmaceutical
By AuntMinnie.com staff writers
Advanced Nuclear Medicine Ingredients (ANMI) has signed an agreement to license a clinical-stage SPECT radiopharmaceutical for prostate cancer imaging from the Mexican Instituto Nacional de Investigaciones Nucleares.
January 24, 2019
2018 04 24 20 24 4264 Isotope 400
Men greatly outnumber women in academic nuclear medicine
By Wayne Forrest
The underrepresentation of women in academic diagnostic radiology has had a ripple effect in nuclear medicine, where men outnumber women by almost 6-to-1 in professorial and leadership positions in the U.S. and Canada, according to a study published in the January issue of the American Journal of Roentgenology.
January 20, 2019
2016 12 30 17 22 48 885 Gender Symbols 400
New PET tracer could aid melanoma detection
By Wayne Forrest
A new PET tracer designed to target melanin pigment could improve the detection of both primary and metastatic melanoma, according to a study published in the January issue of the Journal of Nuclear Medicine.
January 16, 2019
2019 01 17 00 50 4217 Jnm Melanin Pet Tracer 20190117001720
Both sides weigh in on plan to loosen radiopharma rules
By Wayne Forrest
The U.S. Nuclear Regulatory Commission's proposal to create a way for physicians with little or no background in nuclear medicine to become "limited authorized users" and dispense radiopharmaceuticals is drawing both opposition and support from across the healthcare spectrum.
January 15, 2019
2018 12 11 00 02 7009 Atom Nuclear Lab 400
FDA to fast track RadioMedix, Curium PET agent
By AuntMinnie.com staff writers
Biotechnology firm RadioMedix and global nuclear medicine firm Curium have received fast-track designation from the U.S. Food and Drug Administration (FDA) for their PET diagnostic radiopharmaceutical copper-64 DOTATATE.
January 8, 2019
Editorial slams NRC plan to expand radiopharmaceutical users
By Wayne Forrest
An editorial published in the January issue of the Journal of Nuclear Medicine expressed strong objections to actions by the U.S. Nuclear Regulatory Commission (NRC) to promote its alternative pathway for physicians to gain certification to administer radionuclide therapies.
January 6, 2019
2019 01 05 00 38 5275 Molecular Imaging 400
Curium, Progenics partner on PET agent in Europe
By AuntMinnie.com staff writers
Global nuclear medicine firm Curium has joined Progenics Pharmaceuticals in an exclusive agreement to develop and commercialize Progenics' prostate-specific membrane antigen-targeted small molecule PET/CT imaging agent in Europe.
January 2, 2019
Previous Page
Page 16 of 81
Next Page